AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
INDIA'S BIOCON RECEIVES LOCAL NOD TO MARKET BREAST CANCER DRUG.
MUMBAI, Oct 19 Asia Pulse - Leading biotech company Biocon Ltd (BSE:532523) on Thursday said it has received approval from the Drug Controller General of India (DCGI) to market breast-cancer drug Abraxane.
The company had recently announced a licensing agreement with the US-based Abraxis BioScience, Inc for the commercialization of Abraxane in India, Biocon said in a communique to the Bombay Stock Exchange.
Abraxane is an approved drug for the treatment of breast cancer and would facilitate affordable access of high-quality supportive care therapy to cancer patients in India, Biocon said,
The company also informed the ...
- MARKETING RIGHTS FOR NOVARTIS INDIA CANCER DRUG WITHDRAWN.
- News wire article from: AsiaPulse News February 24, 2006 700+ words
...Asia Pulse - Novartis India, subsidiary of Switzerland...granted to it for cancer drug Gleevec by the government of India have been withdrawn...the Patent Office, India on February 17, 2006...for the anti-blood cancer drug was filed overseas...
- India's Non-Small-Cell Lung Cancer Drug Market Will Almost Double by 2013.
- Press release article from: PR Newswire May 13, 2009 700+ words
...finds that the non-small-cell lung cancer drug market in India will almost double by 2013, growing...entitled Non-Small-Cell Lung Cancer in India also finds that Western-branded drug sales in India's non-small-cell lung cancer market...
- Elli Lilly launches anti-cancer drug 'Alimta' in India.
- News wire article from: PTI - The Press Trust of India Ltd. September 18, 2006 700+ words
Elli Lilly launches anti-cancer drug 'Alimta' in India New Delhi, Sep 18 (PTI) US-based pharma company Eli Lilly today launched its anti-cancer drug, 'Alimta', in India. The new drug would be used in combination...
- Roche launches cancer drug Tarveca in India.
- Newspaper article from: Economic Times (New Delhi, India) April 12, 2006 700+ words
Apr. 12--MUMBAI, India -- Pharma major Roche Scientific...announced the launch of its cancer drug, Tarveca (erlotinib), in India. "This drug was launched in...pending for patent approval in India since 1996", he added. It...
- India's Breast Cancer Drug Market Will Almost Double by 2012.
- Press release article from: PR Newswire December 10, 2008 700+ words
...forecasts that the Indian breast cancer drug market will almost double from...report entitled Breast Cancer in India, this growth will be fueled...constraint for market uptake. "India's fast-growing economy...Pharmaceutical Markets in China and India Decision Resources is the FIRST...
- Ayurvedic Cancer drug under trial in the US and India.
- News wire article from: PTI - The Press Trust of India Ltd. February 8, 2006 700+ words
Ayurvedic Cancer drug under trial in the US and India Chennai, Feb 8 (PTI) An Ayurvedic...of trial, both in the US and in India would be released in the market...called "Tumortart," while in India a dozen were under treatment...
- Biocon to market Abraxis' breast cancer drug in India.
- News wire article from: PTI - The Press Trust of India Ltd. August 9, 2007 700+ words
...Biocon to market Abraxis' breast cancer drug in India Mumbai, Aug 9 (PTI) -- Biocon...Inc for selling 'Abraxane' in India, used in treatment of breast cancer...the benefit of patients both in India and other regions of the world...
- INDIA'S NATCO RECALLS BREAST CANCER DRUG 'ALBUPAX'.
- News wire article from: AsiaPulse News July 20, 2009 700+ words
...the production and marketing of breast cancer drug 'Albupax', after tests showed that...Health Regulator Drug Controller General of India (DCGI) DCGI has sent a letter to the...Natco had introduced the product in India in September last year and it recently...